Home/Filings/8-K/0001193125-26-009852
8-K//Current report

Petco Health & Wellness Company, Inc. 8-K

Accession 0001193125-26-009852

$WOOFCIK 0001826470operating

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 8:23 AM ET

Size

154.3 KB

Accession

0001193125-26-009852

Research Summary

AI-generated summary of this filing

Updated

Petco Health & Wellness Announces Debt Refinancing, Reaffirms FY25 Outlook

What Happened
On January 12, 2026, Petco Health & Wellness Company, Inc. announced the launch of a debt refinancing transaction and reiterated its fourth‑quarter and full fiscal year 2025 outlook for Net Sales and Adjusted EBITDA. The company furnished the announcement as Regulation FD disclosure in a press release attached to the Form 8‑K (Exhibit 99.1).

Key Details

  • Announcement date: January 12, 2026 (press release attached as Exhibit 99.1).
  • Event: Launch of a debt refinancing transaction (no financing terms disclosed in the 8‑K).
  • Guidance: Company reaffirmed its Q4 and full fiscal year 2025 outlook for Net Sales and Adjusted EBITDA.
  • Filing items: Reported under Item 7.01 (Regulation FD Disclosure) on Form 8‑K.

Why It Matters
A refinancing transaction can change Petco’s debt profile and future interest or cash flow obligations; the 8‑K itself does not include financing terms, so investors should review the attached press release and expect additional filings or disclosures with transaction details. Reaffirming Q4 and FY2025 Net Sales and Adjusted EBITDA indicates management’s confidence in the company’s near‑term operating results based on current information. Investors focused on capital structure, liquidity and quarterly results should monitor follow‑up disclosures for specifics on deal size, pricing, and timing.